TrialJournal of clinical oncology : official journal of the American Society of Clinical Oncology2020

Results of a Multicenter Phase II Study of Atezolizumab and Bevacizumab for Patients With Metastatic Renal Cell Carcinoma With Variant Histology and/or Sarcomatoid Features.

Bradley A McGregor et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.